In a child with recurrent chest infections, poorly controlled asthma, foul‑smelling stool, and a positive sweat chloride test (~66 mmol/L) indicative of cystic fibrosis, what is the most common associated pulmonary complication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bronchiectasis is the Most Frequent Associated Pulmonary Complication

In a child with cystic fibrosis (CF) confirmed by positive sweat chloride test (~66 mmol/L), recurrent chest infections, poorly controlled asthma-like symptoms, and foul-smelling stools, bronchiectasis (Option B) is the most common associated pulmonary complication.

Clinical Reasoning

The clinical presentation clearly indicates CF:

  • Sweat chloride of 66 mmol/L is diagnostic (≥60 mmol/L confirms CF) 1
  • Foul-smelling stools indicate pancreatic insufficiency with fat malabsorption (steatorrhea), present in >80% of CF patients 1
  • Recurrent chest infections are the hallmark respiratory manifestation of CF 1

Why Bronchiectasis is the Answer

Bronchiectasis is explicitly identified as the predominant pulmonary complication in CF patients. The ACCP evidence-based guidelines specifically list cystic fibrosis as a primary underlying disorder predisposing to bronchiectasis 2. The guidelines state that "with the increasing use of antibiotics in the treatment of childhood infection in the last several decades, an increasing percentage of patients with bronchiectasis now have an underlying disorder that predisposes them to chronic or recurrent infection. These include cystic fibrosis" as the first condition listed 2.

Pathophysiology Supporting This Association

In CF, the defective CFTR protein causes:

  • Abnormally thick, tenacious mucus in airways 2
  • Impaired mucociliary clearance leading to airway plugging 2
  • Recurrent bacterial colonization (especially Pseudomonas aeruginosa) 1
  • Chronic neutrophil-mediated inflammation with elastase and collagenase release 2
  • Progressive destruction of bronchial wall elastic and muscular components 2
  • Permanent bronchial dilation (bronchiectasis) 2

Recent research confirms this: chest CT studies in CF children show bronchiectasis as a significant finding, with sweat chloride levels correlating with bronchiectasis severity scores, particularly in older children 3.

Why Other Options Are Incorrect

A. Pulmonary Emphysema: Not a typical feature of CF in children. CF causes obstructive airway disease from mucus plugging and bronchiectasis, not alveolar destruction characteristic of emphysema.

C. Hypothyroidism: No established association with CF. This is not a recognized complication of the disease.

D. Malignancy: While CF patients have slightly increased cancer risk in adulthood, malignancy is not a frequent or characteristic associated condition in pediatric CF patients.

Clinical Implications

  • High-resolution CT scanning is the preferred diagnostic modality for confirming bronchiectasis 2
  • Early aggressive antibiotic treatment of respiratory infections is critical to prevent chronic P. aeruginosa colonization and progressive bronchiectasis 1
  • Chest physiotherapy and mucolytics are standard components of CF management to prevent bronchiectasis progression 2, 1
  • Children with CF should receive care at specialized CF centers for comprehensive multidisciplinary management 1

Common Pitfall to Avoid

Don't dismiss the diagnosis of CF based solely on the clinical presentation of "poorly controlled asthma." Many CF patients are initially misdiagnosed with asthma or bronchitis before the correct diagnosis is established 1. The combination of respiratory symptoms with gastrointestinal manifestations (foul-smelling stools) and positive sweat chloride should immediately trigger consideration of CF with bronchiectasis as the underlying pathology.

Related Questions

In a child with recurrent sinopulmonary infections, failure to thrive, and possible pancreatic insufficiency, what is the likelihood of cystic fibrosis and what is the next diagnostic step?
What is the most appropriate diagnostic test for a 9-month-old infant with wheezing, labored breathing, productive cough, malodorous and greasy stools, and failure to gain weight, with a history of meconium ileus at birth?
What are the diagnostic criteria and key investigations needed to diagnose cystic fibrosis in a patient?
What are all the clinical manifestations of cystic fibrosis and their underlying pathophysiology?
What are the differential diagnoses of cystic fibrosis and how are they distinguished?
What gastrointestinal medications are appropriate for a 29-year-old patient with a history of colitis?
Can vitamin D supplementation cause dizziness?
Can levothyroxine 25 µg be administered once daily?
For a patient with elevated red blood cell count, elevated hematocrit, low mean corpuscular hemoglobin, fasting glucose of 118 mg/dL, AST 60 U/L, ALT 106 U/L, total testosterone 75 ng/dL, hemoglobin A1c 6.2 %, and vitamin D 10.9 ng/mL, what is the interpretation of these labs and what management steps should be taken?
Can a woman undergo radiofrequency ablation (RFA) to shrink uterine fibroids and then attempt pregnancy?
In a 65-year-old man with diabetes mellitus who has recovered from bacterial pneumonia and is being discharged, what preventive intervention should be administered?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.